A new cancer drug targets biomarkers that don’t depend of where cancer is located in the body.
Laura Dixon has a long history with cancer.
She was diagnosed with colon cancer in 1996, pancreatic cancer in 2013, and ovarian and endometrial cancer in 2014. Her treatment included several surgeries and a variety of chemotherapy drugs.
In 2015, a tumor in her liver turned out to be a pancreatic cancer recurrence.
But things were different this time.
The 49-year-old resident of Columbus, Ohio, had access to a clinical trial and a previously approved cancer drug called Keytruda. The clinical trial took place at The Ohio State University Comprehensive Cancer Center.
Read full article: Cancer Treatment with Biomarkers
|Read Full Article: Cancer Treatment with Biomarkers|